Form4insider filings, from the source

SEC Form 4 · accession 0000899243-16-021423

REATA PHARMACEUTICALS INC · RETA

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owners
William Rose
Director · Other
Period of report
Jun 1, 2016
Accepted (ET)
Jun 2, 2016 · 6:21 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001358762

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Class A Common StockF1,F2Jun 1, 2016C11,618—A11,618D
Class A Common StockF1,F3Jun 1, 2016C168,720—A168,720D
Class A Common StockF1,F4Jun 1, 2016C7,886—A7,886D
Class A Common StockF1,F5Jun 1, 2016C1,426—A1,426D
Class A Common StockF1,F5Jun 1, 2016C29—A29D
Class A Common StockF1,F7Jun 1, 2016C20—A20IBy trust
Class A Common StockF1,F8Jun 1, 2016C45—A45IBy trust
Class A Common StockF9Jun 1, 2016P957,000$11.00A957,000IBy Puffin
Class A Common StockF10Jun 1, 2016P143,000$11.00A143,000IBy Montrose

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Class B Common StockF2,F1—Jun 1, 2016C11,618D——Class A Common Stock11,618129,308D
Class B Common StockF3,F1—Jun 1, 2016C168,720D——Class A Common Stock168,7201,877,998D
Class B Common StockF4,F1—Jun 1, 2016C7,886D——Class A Common Stock7,88687,776D
Class B Common StockF5,F1—Jun 1, 2016C1,426D——Class A Common Stock1,42615,869D
Class B Common StockF6,F1—Jun 1, 2016C29D——Class A Common Stock29313D
Class B Common StockF7,F1—Jun 1, 2016C20D——Class A Common Stock20215I
Class B Common StockF8,F1—Jun 1, 2016C45D——Class A Common Stock45492I

Explanation of responses

Remarks

Each Reporting Owner disclaims beneficial ownership of the reporting securities in excess of their pecuniary interests therein.